Owner Wyeth Holdings Corporation

Inventors Damle, Nitin Krishnaji; Dijoseph, John Francis; Jain, Neera; Kunz, Arthur; Merchant, Nishith; Moran, Justin Keith; Popplewell, Andrew George; Robbins, Paul David; Rubino, Joseph Thomas; Ruppen, Mark Edward; Simpson, John McLean; Vidunas, Eugene Joseph

Agent Spruson & Ferguson

Pub. Number AU-B-2009202609

Parent 2003231293

Filing date 26 June 2009

Wipo publication date 16 July 2009

Acceptance publication date 26 July 2012

C07K 1/16 General processes for the preparation of peptides

A61K 9/19 Medicinal preparations characterised by special physical form - lyophilised

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 41/00 Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 47/26 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/36 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/38 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 Antineoplastic agents

A61P 35/02 Antineoplastic agents

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies